The 15th Annual HAI conference highlighted developments in neuroimaging research.
Congratulations, Dr. Johnson!
The national workgroup is charged with establishing definitions and classifications of AD.
The newest WRAP Update is available now.
Save the date for an upcoming Info Session near you
On September 27, pharmaceutical companies Eisai and Biogen released a statement describing results from an experimental drug, lecanemab, that showed a potential reduction of clinical decline in a study of people with early Alzheimer’s disease. …
Staff members from WRAP and Brain biomarker lab were able to meet together for an all staff retreat in late September. The day was a day for organizational planning, connecting and important conversations about how …
WRAP PI Sterling Johnson, Phd, joined the June 21 Badger Talks podcast to discuss latest advances in Alzheimer’s disease research.
Dr. Chin is medical director for WRAP, overseeing clinical care provided to the roughly 5,000 volunteers who participate in campus Alzheimer’s disease research studies.
The spring 2022 WRAP Update is available now.